Developing improved HIV vaccines using sequential immunization strategies
Immune engineering of optimized sequential immunization strategies for HIV vaccines
This study is working on a new HIV vaccine that uses a special approach to help your immune system make powerful antibodies to fight the virus, and it aims to find the best way to give the vaccine so it can be used safely around the world.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11220630 on NIH RePORTER |
What this research studies
This research focuses on creating a more effective HIV vaccine by using a method called sequential immunization, which aims to guide the immune system's B cells to produce broadly neutralizing antibodies (bnAbs) that can protect against HIV infection. The researchers will conduct systematic studies in small animal models to explore key immunological questions, such as the timing of vaccine doses and how to overcome competition from non-neutralizing B cells. By addressing these challenges, the goal is to develop a practical vaccine that can be administered globally, even if it requires multiple injections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for HIV infection who are interested in participating in vaccine trials.
Not a fit: Patients who are already living with HIV or those who have contraindications to vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking HIV vaccine that provides effective protection against the virus.
How similar studies have performed: Other research has shown promise in using sequential immunization strategies to elicit bnAbs, indicating that this approach has potential for success.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Irvine, Darrell J — Scripps Research Institute, the
- Study coordinator: Irvine, Darrell J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.